US Drug Recall Register
Class I · High risk Terminated Initiated Mar 18, 2015 (11 years ago)

Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL), 2 mL Single-dose Vial, packaged in 5 x…

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Presence of Particulate Matter

What was recalled

Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL), 2 mL Single-dose Vial, packaged in 5 x 2 mL vials per carton, Rx only, labeled as a) Distributed by Pfizer Labs, Division of Pfizer Inc., New York, NY 10017, NDC 0069-0146-01; and b) Manufactured for: Mylan Institutional LLC, Rockford, IL 61103, NDC 67457-467-99.

Recalling firm
Mylan Institutional LLC
NDC code
0069-0146-01
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1328-2015

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Methotrexate recalls

See all